by adminAdrianRamirez | Apr 17, 2019 | HempMeds Brasil, Press Releases
SAN DIEGO, April 17, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in international media outlet BloombergNews. An April 16, 2019 article entitled,...
by adminAdrianRamirez | Apr 4, 2019 | HempMeds, HempMeds Brasil, Kannaway, Press Releases
SAN DIEGO, April 4, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company had its the largest-ever (unaudited) sales month in its history in March 2019. The company also...
by adminAdrianRamirez | Apr 1, 2019 | HempMeds Brasil, Press Releases
SAN DIEGO, April 1, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil will be sponsoring TEAbraco 2019 International Autism Week from April 1 to April...
by adminAdrianRamirez | Mar 22, 2019 | Dixie Botanicals, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Press Releases
First Publicly-Traded Cannabis Company Observes Decade of Achievements SAN DIEGO, March 22, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company is celebrating its...
by adminAdrianRamirez | Mar 18, 2019 | HempMeds Brasil, Press Releases
SAN DIEGO, March 18, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is hosting an event on Medical Cannabis at the Fera Palace Hotel in the Historic...
by adminAdrianRamirez | Feb 5, 2019 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 5, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil hosted its second Cannabinoid Medicine course on Feb. 1, 2019, at the HempMeds®...